Hassard James 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Mar 3, 2023
Insider Transaction Report
Form 4
Hassard James
Chief Commercial Officer
Transactions
- Award
Common Stock
2023-03-01+14,000→ 14,000 total - Award
Stock Option (right to buy)
2023-03-01+65,250→ 65,250 totalExercise: $19.64Exp: 2033-02-28→ Common Stock (65,250 underlying)
Footnotes (2)
- [F1]The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 15, 2024.
- [F2]The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of March 1, 2023.